Trial Profile
A phase I, open label steady-state pharmacokinetic study of Brivaracetam and Lamotrigine in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Feb 2016
Price :
$35
*
At a glance
- Drugs Brivaracetam (Primary) ; Lamotrigine (Primary)
- Indications Partial epilepsies
- Focus Pharmacokinetics
- 23 Feb 2016 New trial record